| |
Chordoma / chondrosarcoma
| | |
|---|
|
Variable
|
Group 1
|
Group 2
|
Group 3
|
p-value
|
Combined cohort
|
|---|
|
Skull and face
|
Vertebral column
|
Sacrum/ coccyx
|
|---|
|
Total N = 2041
|
n = 1214 (69.1%)
|
n = 297 (16.9%)
|
n = 246 (14%)
|
N = 1757
|
|---|
|
Demographics
|
|
Age
| | | |
<.0001
| |
|
Mean (SD)
|
57.4 (15.8)
|
49.5 (17)
|
47.9 (17.2)
| |
54.8 (16.7)
|
|
Median (IQR)
|
58 (49, 69)
|
52 (37, 62)
|
49 (35, 61)
| |
56 (45, 65)
|
|
Range, min-max)
|
18–96
|
18–88
|
18–89
| |
18–96
|
|
Gender: female, n (%)
|
519 (42.7%)
|
144 (48.4%)
|
109 (44.3%)
|
0.2018
|
772 (43.9%)
|
|
Insurance
| | | |
<.0001
| |
|
Commercial, n (%)
|
726 (59.8%)
|
203 (68.3%)
|
181 (73.5%)
| |
1110 (63.1%)
|
|
Medicaid, n (%)
|
144 (11.8%)
|
42 (14.1%)
|
30 (12.2%)
| |
216 (12.2%)
|
|
Medicare, n (%)
|
344 (28.3%)
|
52 (17.5%)
|
35 (14.2%)
| |
431 (24.5%)
|
|
Elixhauser index
| | | |
0.054
| |
|
1, n (%)
|
415 (34.1%)
|
85 (28.6%)
|
72 (29.2%)
|
0.054
|
572 (32.5%)
|
|
2, n (%)
|
468 (38.5%)
|
123 (41.4%)
|
87 (35.3%)
| |
678 (38.5%)
|
|
3+, n (%)
|
1214 (17%)
|
297 (15.3%)
|
246 (14.1%)
| |
1757 (28%)
|
